Paraguay Government Grants Historic Import Permit for Medical Marijuana, Inc.’s Real Scientific Hemp Oil™ Into Paraguay for Treatment of Epilepsy
Real Scientific Hemp Oil™ (RSHO™) Cannabidiol (CBD) Hemp Oil Demand Grows as Countries Including Brazil, Mexico, Puerto Rico and Paraguay Authorize Its Import From the U.S.
Medical Marijuana, Inc. (OTC: MJNA) is pleased to announce that its flagship product Real Scientific Hemp Oil™ (RSHO™) has been authorized by Paraguay’s government for import into the country as a prescription medication for refractory epilepsy.
Paraguay’s first-ever import permit for RSHO™ marks the fourth country in Latin America, after Brazil, Puerto Rico, and Mexico, to approve MJNA’s cannabidiol (CBD) hemp oil for indications including epilepsy, Parkinson’s disease, chronic pain, and cancer.
The first shipment of RSHO™ into Paraguay was authorized for 15-year-old Mathias Alejandro Gonzalez, who was diagnosed with an autism spectrum disorder and suffers from Lennox-Gastaut Syndrome (LGS), a rare type of epilepsy that doesn’t respond well to seizure medications.
“We are extremely proud of the wonderful news that RSHO™ has been approved for import by the government of Paraguay,” states Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. “In the U.S., we enjoy the ability to easily access RSHO™ and many other CBD hemp oil products online. However, in other countries, we must respect their regulations and handling of cannabis-based products including hemp.”
“MJNA is a ‘Company of Firsts’,” Titus continues. “It took many years to establish and streamline a standardized commercial system while developing the world’s first CBD hemp oil pipeline. We are extremely grateful to our investors who also saw and continue to see the vision of CBD hemp oil access in the U.S. and around the world.”
In February of 2015, HempMeds® received authorization to export Real Scientific Hemp Oil-X™ (RSHO-X™) to individuals in Mexico with government-issued import permits. Raul and Mayela Elizalde from the Por Grace Foundation, based in Mexico, helped explain their daughter Grace’s need for the cannabidiol (CBD) hemp oil product for a case similar to that of Mathias Gonzalez’s family in Paraguay -- and were instrumental in the process of securing the permit. Since 2014, the government of Brazil continues to issue import permits for RSHO™, as well as subsidize payments for the product under the federal government’s healthcare system -- and also waive import taxes.
# # #
For further information, please contact:
Public Relations contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829-0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Investor Relations:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana Inc.
OTC Symbol: MJNA
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6505
Email: Nick@MedicalMarijuanainc.com
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Tags:
